| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |